Gavi Receives $400 Million in Donations at High-Level Event To Expand Global Access to COVID-19 Vaccines 15/04/2021 Editorial team In a vital step forward that will help accelerate global access to COVID-19 vaccines, Gavi, the vaccine alliance raised some $400 million in donations at a high-level event on Thursday, just a week after the global COVAX facility reached 100 countries with almost 40 million vaccine doses. The event was hosted by US Secretary of […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> India Set To Become Major Manufacturing Hub Of Sputnik V COVID Vaccine – Regulatory Approval Comes As COVID Cases Spike 14/04/2021 Menaka Rao India has greenlighted Russia’s Sputnik V vaccine for emergency use following a severe shortage of vaccines against the coronavirus and a massive spike in cases, and is now poised to become one of the world’s largest manufacturing hubs for the vaccine with 50 million doses produced by July. India’s aproval of a third COVID vaccine […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> The Clock Is Ticking For Vaccine Equity, But WHO Remains Hopeful 01/04/2021 Svĕt Lustig Vijay The World Health Organization (WHO) is hopeful that all healthcare workers can be vaccinated by mid-April, but the clock is ticking away, leaving rich countries only nine days to donate surplus COVID-19 vaccines to the global COVAX facility – which has run out of doses at a crucial time. So far, the WHO has not […] Continue reading -> AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union 22/03/2021 Madeleine Hoecklin In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading -> Aspirin May Help Protect Against COVID-19 Infection & Serious Disease: New Peer-Reviewed Study Suggests 10/03/2021 Editorial team A study of people taking regular, low doses of aspirin found that the aspirin users were 29% less likely than others to test positive for COVID-19, as well as being less prone to serious disease and its “long COVID” after-effects. The new peer-reviewed study, published in The FEBS Journal of the Federation of European Biochemical […] Continue reading -> The European Medicines Agency’s COVID-19 Vaccine Leaks: Hacks, Regulatory Pressures And Manufacturing Concerns 23/02/2021 Priti Patnaik & Lucien Hordijk EXCLUSIVE – A series of recent leaks of emails and documents surrounding the EMA’s approval of the first COVID-19 vaccine by Pfizer/BioNTech highlight the intense political pressures regulatory agencies are under during the pandemic – as well as an oft-forgotten aspect of vaccine approvals – the quality control of vaccines during the leap from clinical […] Continue reading -> G-7 Commitments Of US$4.3 Billion Not Enough – Rich Countries Need To Stop COVID Vaccine Hoarding to Open Access Bottleneck, Says WHO Director General 22/02/2021 Kerry Cullinan Despite Friday’s commitment by G-7 countries to donate another US$ 4.3 billion to a global COVID vaccine campaign, World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has accused high-income nations of still undermining equitable vaccine rollout by “doing deals” with manufacturers that deplete supplies available to the COVAX global vaccine facility. Speaking at the […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> India Set To Become Major Manufacturing Hub Of Sputnik V COVID Vaccine – Regulatory Approval Comes As COVID Cases Spike 14/04/2021 Menaka Rao India has greenlighted Russia’s Sputnik V vaccine for emergency use following a severe shortage of vaccines against the coronavirus and a massive spike in cases, and is now poised to become one of the world’s largest manufacturing hubs for the vaccine with 50 million doses produced by July. India’s aproval of a third COVID vaccine […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> The Clock Is Ticking For Vaccine Equity, But WHO Remains Hopeful 01/04/2021 Svĕt Lustig Vijay The World Health Organization (WHO) is hopeful that all healthcare workers can be vaccinated by mid-April, but the clock is ticking away, leaving rich countries only nine days to donate surplus COVID-19 vaccines to the global COVAX facility – which has run out of doses at a crucial time. So far, the WHO has not […] Continue reading -> AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union 22/03/2021 Madeleine Hoecklin In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading -> Aspirin May Help Protect Against COVID-19 Infection & Serious Disease: New Peer-Reviewed Study Suggests 10/03/2021 Editorial team A study of people taking regular, low doses of aspirin found that the aspirin users were 29% less likely than others to test positive for COVID-19, as well as being less prone to serious disease and its “long COVID” after-effects. The new peer-reviewed study, published in The FEBS Journal of the Federation of European Biochemical […] Continue reading -> The European Medicines Agency’s COVID-19 Vaccine Leaks: Hacks, Regulatory Pressures And Manufacturing Concerns 23/02/2021 Priti Patnaik & Lucien Hordijk EXCLUSIVE – A series of recent leaks of emails and documents surrounding the EMA’s approval of the first COVID-19 vaccine by Pfizer/BioNTech highlight the intense political pressures regulatory agencies are under during the pandemic – as well as an oft-forgotten aspect of vaccine approvals – the quality control of vaccines during the leap from clinical […] Continue reading -> G-7 Commitments Of US$4.3 Billion Not Enough – Rich Countries Need To Stop COVID Vaccine Hoarding to Open Access Bottleneck, Says WHO Director General 22/02/2021 Kerry Cullinan Despite Friday’s commitment by G-7 countries to donate another US$ 4.3 billion to a global COVID vaccine campaign, World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has accused high-income nations of still undermining equitable vaccine rollout by “doing deals” with manufacturers that deplete supplies available to the COVAX global vaccine facility. Speaking at the […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Gates Foundation: Technology Transfer, Not Patents Is Main Roadblock To Expanding Vaccine Production 14/04/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Patents are not the main roadblock to producing enough coronavirus vaccines for the world – rather the challenge is technology transfer with manufacturers, said a top official at the Bill and Melinda Gates Foundation (BMGF) on Wednesday. His comments joined those of pharma voices in what seems to be a growing counter-trend to that of […] Continue reading -> India Set To Become Major Manufacturing Hub Of Sputnik V COVID Vaccine – Regulatory Approval Comes As COVID Cases Spike 14/04/2021 Menaka Rao India has greenlighted Russia’s Sputnik V vaccine for emergency use following a severe shortage of vaccines against the coronavirus and a massive spike in cases, and is now poised to become one of the world’s largest manufacturing hubs for the vaccine with 50 million doses produced by July. India’s aproval of a third COVID vaccine […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> The Clock Is Ticking For Vaccine Equity, But WHO Remains Hopeful 01/04/2021 Svĕt Lustig Vijay The World Health Organization (WHO) is hopeful that all healthcare workers can be vaccinated by mid-April, but the clock is ticking away, leaving rich countries only nine days to donate surplus COVID-19 vaccines to the global COVAX facility – which has run out of doses at a crucial time. So far, the WHO has not […] Continue reading -> AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union 22/03/2021 Madeleine Hoecklin In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading -> Aspirin May Help Protect Against COVID-19 Infection & Serious Disease: New Peer-Reviewed Study Suggests 10/03/2021 Editorial team A study of people taking regular, low doses of aspirin found that the aspirin users were 29% less likely than others to test positive for COVID-19, as well as being less prone to serious disease and its “long COVID” after-effects. The new peer-reviewed study, published in The FEBS Journal of the Federation of European Biochemical […] Continue reading -> The European Medicines Agency’s COVID-19 Vaccine Leaks: Hacks, Regulatory Pressures And Manufacturing Concerns 23/02/2021 Priti Patnaik & Lucien Hordijk EXCLUSIVE – A series of recent leaks of emails and documents surrounding the EMA’s approval of the first COVID-19 vaccine by Pfizer/BioNTech highlight the intense political pressures regulatory agencies are under during the pandemic – as well as an oft-forgotten aspect of vaccine approvals – the quality control of vaccines during the leap from clinical […] Continue reading -> G-7 Commitments Of US$4.3 Billion Not Enough – Rich Countries Need To Stop COVID Vaccine Hoarding to Open Access Bottleneck, Says WHO Director General 22/02/2021 Kerry Cullinan Despite Friday’s commitment by G-7 countries to donate another US$ 4.3 billion to a global COVID vaccine campaign, World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has accused high-income nations of still undermining equitable vaccine rollout by “doing deals” with manufacturers that deplete supplies available to the COVAX global vaccine facility. Speaking at the […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
India Set To Become Major Manufacturing Hub Of Sputnik V COVID Vaccine – Regulatory Approval Comes As COVID Cases Spike 14/04/2021 Menaka Rao India has greenlighted Russia’s Sputnik V vaccine for emergency use following a severe shortage of vaccines against the coronavirus and a massive spike in cases, and is now poised to become one of the world’s largest manufacturing hubs for the vaccine with 50 million doses produced by July. India’s aproval of a third COVID vaccine […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> The Clock Is Ticking For Vaccine Equity, But WHO Remains Hopeful 01/04/2021 Svĕt Lustig Vijay The World Health Organization (WHO) is hopeful that all healthcare workers can be vaccinated by mid-April, but the clock is ticking away, leaving rich countries only nine days to donate surplus COVID-19 vaccines to the global COVAX facility – which has run out of doses at a crucial time. So far, the WHO has not […] Continue reading -> AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union 22/03/2021 Madeleine Hoecklin In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading -> Aspirin May Help Protect Against COVID-19 Infection & Serious Disease: New Peer-Reviewed Study Suggests 10/03/2021 Editorial team A study of people taking regular, low doses of aspirin found that the aspirin users were 29% less likely than others to test positive for COVID-19, as well as being less prone to serious disease and its “long COVID” after-effects. The new peer-reviewed study, published in The FEBS Journal of the Federation of European Biochemical […] Continue reading -> The European Medicines Agency’s COVID-19 Vaccine Leaks: Hacks, Regulatory Pressures And Manufacturing Concerns 23/02/2021 Priti Patnaik & Lucien Hordijk EXCLUSIVE – A series of recent leaks of emails and documents surrounding the EMA’s approval of the first COVID-19 vaccine by Pfizer/BioNTech highlight the intense political pressures regulatory agencies are under during the pandemic – as well as an oft-forgotten aspect of vaccine approvals – the quality control of vaccines during the leap from clinical […] Continue reading -> G-7 Commitments Of US$4.3 Billion Not Enough – Rich Countries Need To Stop COVID Vaccine Hoarding to Open Access Bottleneck, Says WHO Director General 22/02/2021 Kerry Cullinan Despite Friday’s commitment by G-7 countries to donate another US$ 4.3 billion to a global COVID vaccine campaign, World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has accused high-income nations of still undermining equitable vaccine rollout by “doing deals” with manufacturers that deplete supplies available to the COVAX global vaccine facility. Speaking at the […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> The Clock Is Ticking For Vaccine Equity, But WHO Remains Hopeful 01/04/2021 Svĕt Lustig Vijay The World Health Organization (WHO) is hopeful that all healthcare workers can be vaccinated by mid-April, but the clock is ticking away, leaving rich countries only nine days to donate surplus COVID-19 vaccines to the global COVAX facility – which has run out of doses at a crucial time. So far, the WHO has not […] Continue reading -> AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union 22/03/2021 Madeleine Hoecklin In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading -> Aspirin May Help Protect Against COVID-19 Infection & Serious Disease: New Peer-Reviewed Study Suggests 10/03/2021 Editorial team A study of people taking regular, low doses of aspirin found that the aspirin users were 29% less likely than others to test positive for COVID-19, as well as being less prone to serious disease and its “long COVID” after-effects. The new peer-reviewed study, published in The FEBS Journal of the Federation of European Biochemical […] Continue reading -> The European Medicines Agency’s COVID-19 Vaccine Leaks: Hacks, Regulatory Pressures And Manufacturing Concerns 23/02/2021 Priti Patnaik & Lucien Hordijk EXCLUSIVE – A series of recent leaks of emails and documents surrounding the EMA’s approval of the first COVID-19 vaccine by Pfizer/BioNTech highlight the intense political pressures regulatory agencies are under during the pandemic – as well as an oft-forgotten aspect of vaccine approvals – the quality control of vaccines during the leap from clinical […] Continue reading -> G-7 Commitments Of US$4.3 Billion Not Enough – Rich Countries Need To Stop COVID Vaccine Hoarding to Open Access Bottleneck, Says WHO Director General 22/02/2021 Kerry Cullinan Despite Friday’s commitment by G-7 countries to donate another US$ 4.3 billion to a global COVID vaccine campaign, World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has accused high-income nations of still undermining equitable vaccine rollout by “doing deals” with manufacturers that deplete supplies available to the COVAX global vaccine facility. Speaking at the […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
The Clock Is Ticking For Vaccine Equity, But WHO Remains Hopeful 01/04/2021 Svĕt Lustig Vijay The World Health Organization (WHO) is hopeful that all healthcare workers can be vaccinated by mid-April, but the clock is ticking away, leaving rich countries only nine days to donate surplus COVID-19 vaccines to the global COVAX facility – which has run out of doses at a crucial time. So far, the WHO has not […] Continue reading -> AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union 22/03/2021 Madeleine Hoecklin In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading -> Aspirin May Help Protect Against COVID-19 Infection & Serious Disease: New Peer-Reviewed Study Suggests 10/03/2021 Editorial team A study of people taking regular, low doses of aspirin found that the aspirin users were 29% less likely than others to test positive for COVID-19, as well as being less prone to serious disease and its “long COVID” after-effects. The new peer-reviewed study, published in The FEBS Journal of the Federation of European Biochemical […] Continue reading -> The European Medicines Agency’s COVID-19 Vaccine Leaks: Hacks, Regulatory Pressures And Manufacturing Concerns 23/02/2021 Priti Patnaik & Lucien Hordijk EXCLUSIVE – A series of recent leaks of emails and documents surrounding the EMA’s approval of the first COVID-19 vaccine by Pfizer/BioNTech highlight the intense political pressures regulatory agencies are under during the pandemic – as well as an oft-forgotten aspect of vaccine approvals – the quality control of vaccines during the leap from clinical […] Continue reading -> G-7 Commitments Of US$4.3 Billion Not Enough – Rich Countries Need To Stop COVID Vaccine Hoarding to Open Access Bottleneck, Says WHO Director General 22/02/2021 Kerry Cullinan Despite Friday’s commitment by G-7 countries to donate another US$ 4.3 billion to a global COVID vaccine campaign, World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has accused high-income nations of still undermining equitable vaccine rollout by “doing deals” with manufacturers that deplete supplies available to the COVAX global vaccine facility. Speaking at the […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union 22/03/2021 Madeleine Hoecklin In news that should be reassuring for skeptics, the Oxford/AstraZeneca COVID-19 vaccine was found to be 79% effective in preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in results of a late-stage clinical trial, published today by the pharma company. What’s more, analysis of safety results by an independent board found no […] Continue reading -> Aspirin May Help Protect Against COVID-19 Infection & Serious Disease: New Peer-Reviewed Study Suggests 10/03/2021 Editorial team A study of people taking regular, low doses of aspirin found that the aspirin users were 29% less likely than others to test positive for COVID-19, as well as being less prone to serious disease and its “long COVID” after-effects. The new peer-reviewed study, published in The FEBS Journal of the Federation of European Biochemical […] Continue reading -> The European Medicines Agency’s COVID-19 Vaccine Leaks: Hacks, Regulatory Pressures And Manufacturing Concerns 23/02/2021 Priti Patnaik & Lucien Hordijk EXCLUSIVE – A series of recent leaks of emails and documents surrounding the EMA’s approval of the first COVID-19 vaccine by Pfizer/BioNTech highlight the intense political pressures regulatory agencies are under during the pandemic – as well as an oft-forgotten aspect of vaccine approvals – the quality control of vaccines during the leap from clinical […] Continue reading -> G-7 Commitments Of US$4.3 Billion Not Enough – Rich Countries Need To Stop COVID Vaccine Hoarding to Open Access Bottleneck, Says WHO Director General 22/02/2021 Kerry Cullinan Despite Friday’s commitment by G-7 countries to donate another US$ 4.3 billion to a global COVID vaccine campaign, World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has accused high-income nations of still undermining equitable vaccine rollout by “doing deals” with manufacturers that deplete supplies available to the COVAX global vaccine facility. Speaking at the […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Aspirin May Help Protect Against COVID-19 Infection & Serious Disease: New Peer-Reviewed Study Suggests 10/03/2021 Editorial team A study of people taking regular, low doses of aspirin found that the aspirin users were 29% less likely than others to test positive for COVID-19, as well as being less prone to serious disease and its “long COVID” after-effects. The new peer-reviewed study, published in The FEBS Journal of the Federation of European Biochemical […] Continue reading -> The European Medicines Agency’s COVID-19 Vaccine Leaks: Hacks, Regulatory Pressures And Manufacturing Concerns 23/02/2021 Priti Patnaik & Lucien Hordijk EXCLUSIVE – A series of recent leaks of emails and documents surrounding the EMA’s approval of the first COVID-19 vaccine by Pfizer/BioNTech highlight the intense political pressures regulatory agencies are under during the pandemic – as well as an oft-forgotten aspect of vaccine approvals – the quality control of vaccines during the leap from clinical […] Continue reading -> G-7 Commitments Of US$4.3 Billion Not Enough – Rich Countries Need To Stop COVID Vaccine Hoarding to Open Access Bottleneck, Says WHO Director General 22/02/2021 Kerry Cullinan Despite Friday’s commitment by G-7 countries to donate another US$ 4.3 billion to a global COVID vaccine campaign, World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has accused high-income nations of still undermining equitable vaccine rollout by “doing deals” with manufacturers that deplete supplies available to the COVAX global vaccine facility. Speaking at the […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
The European Medicines Agency’s COVID-19 Vaccine Leaks: Hacks, Regulatory Pressures And Manufacturing Concerns 23/02/2021 Priti Patnaik & Lucien Hordijk EXCLUSIVE – A series of recent leaks of emails and documents surrounding the EMA’s approval of the first COVID-19 vaccine by Pfizer/BioNTech highlight the intense political pressures regulatory agencies are under during the pandemic – as well as an oft-forgotten aspect of vaccine approvals – the quality control of vaccines during the leap from clinical […] Continue reading -> G-7 Commitments Of US$4.3 Billion Not Enough – Rich Countries Need To Stop COVID Vaccine Hoarding to Open Access Bottleneck, Says WHO Director General 22/02/2021 Kerry Cullinan Despite Friday’s commitment by G-7 countries to donate another US$ 4.3 billion to a global COVID vaccine campaign, World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has accused high-income nations of still undermining equitable vaccine rollout by “doing deals” with manufacturers that deplete supplies available to the COVAX global vaccine facility. Speaking at the […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
G-7 Commitments Of US$4.3 Billion Not Enough – Rich Countries Need To Stop COVID Vaccine Hoarding to Open Access Bottleneck, Says WHO Director General 22/02/2021 Kerry Cullinan Despite Friday’s commitment by G-7 countries to donate another US$ 4.3 billion to a global COVID vaccine campaign, World Health Organization Director General, Dr Tedros Adhanom Ghebreyesus has accused high-income nations of still undermining equitable vaccine rollout by “doing deals” with manufacturers that deplete supplies available to the COVAX global vaccine facility. Speaking at the […] Continue reading -> Posts navigation Older posts